Innovation for Health - 14 February 2019
Global Investor Forum Contact
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare

Kees Been

CEO, Lysosomal Therapeutics Inc.

Session

18:30 - 21:00
Keynote VIP CEO-Investor Dinner

Kees is CEO of Lysosomal Therapeutics Inc (LTI), a biotech company focused on probing the lysosomal enzyme system for new drug targets in neurodegenerative diseases. Specifically, it is leveraging the genetic link between Gaucher’s and Parkinson’s disease (PD) to develop compounds that enhance the lysosomal glucocerebrosidase enzyme activity as an entirely new and breakthrough class of agents for the personalized and disease-modifying treatment in PD. The company is currently working toward an exit as part of its option-to-buy collaboration with Allergan. He was formerly CEO of EnVivo Pharmaceuticals (changed to FORUM Pharmaceuticals) for eight years working on cognition drugs for Alzheimer's and schizophrenia. He spent four years at Biogen, where he directed the Oncology Business Unit which was sold to Idec, and was head of Business Development.
Kees holds an MBA degree from INSEAD in France and graduated from the University of Agriculture in Holland, majoring in Molecular Biology and Process Engineering. Kees likes to spend his weekend mornings flying his single-engine airplane, exploring local airports in the New England area that offer brunch menus

Abstract

Lysosomal Therapeutics, a journey of discovery

Henk van Houten
Royal Philips

Henk van Houten
Edwin Moses
Ablynx
Edwin Moses

Peter Paul van Benthem
Dutch Association of Medical Specialists

Peter Paul van Benthem
Niels Chavannes
LUMC
Niels Chavannes

Madelon Maurice
UMC Utrecht & Oncode Institute

Madelon Maurice
Ingmar de Gooijer
myTomorrows
Ingmar de Gooijer
Tom Miller
GreyBird Ventures
Tom Miller
Mark van Houdenhoven
Sint Maartenskliniek
Mark van Houdenhoven
Ruben Kok
Dutch Techcentre for Life Sciences
Ruben Kok
Colja Laane
Mibiton
Colja Laane

Arthur Lahr
Kiadis Pharma

Arthur Lahr
Eveliene Manten-Horst
AYA Jongvolwassen & Kanker
Eveliene Manten-Horst
Kas Maessen
NWO Grootschalig Infrastructuur
Kas Maessen
Eline Vrijland-van Beest
NightBalance
Eline Vrijland-van Beest
Jos Malda
UMC Utrecht
Jos Malda
Lucien Hordijk
Journalist
Maarten van Dongen
LabForRent
Maarten van Dongen
Kees Recourt
Mibiton Foundation
Kees Recourt

Maurits van Selms
ACTA

Maurits Selms
Marianne van der Steen
MERLN
Marianne van der Steen
Werner Verbiest
Janssen Diagnostics
Werner Verbiest
Markwin Velders
Kite Pharma
Markwin Velders
Nicolas Vergauwe
miDiagnostics
Nicolas Vergauwe

Marc Schellekens
LabHotel Rotterdam

Marc Schellekens
Bert-Arjan Millenaar
NLC The Healthtec Venture Builder
Bert-Arjan Millenaar
Phil L'Huillier
MSD
Jeff Gielen
Kadans Science Partner
Jeff Gielen
Annemiek Verkamman
HollandBIO
Ton van der Steen
Erasmus MC Medical Delta
Hans Schikan
Health~Holland
Joep de Groot
CbusineZ
Joep de Groot
Peter Hinssen
nexxworks
Sponsors & Partners
Main partner
Health~Holland
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Sponsor
Kempen
Partner
Vereniging Innovatieve Geneesmiddelen
Partner
Global Investor Forum
Your logo?
Become a sponsor of Innovation for Health 2019!
© 2018 Innovation for Health